ethambutol has been researched along with Latent Tuberculosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
| Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
| George, S; Gerbo, RM; Hartman-Adams, H | 1 |
| Marks, SM; Mase, SR; Morris, SB | 1 |
| Leong, BCS; Lightman, S; McCluskey, PJ; Tomkins-Netzer, O; Zhang, X | 1 |
| Chinnakotla, S; Hassan, MA; Obeid, KM; Young, JH | 1 |
| Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK | 1 |
| Allen, SJ; Carlson, SL; Furukawa, NW; Haider, MZ; Lindquist, SW | 1 |
| Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G | 1 |
2 review(s) available for ethambutol and Latent Tuberculosis
| Article | Year |
|---|---|
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Disease Progression; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Latent Tuberculosis; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2017 |
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
7 other study(ies) available for ethambutol and Latent Tuberculosis
| Article | Year |
|---|---|
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
Tuberculosis: Common Questions and Answers.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; Tuberculin; Tuberculosis; United States | 2022 |
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Ocular; Uveitis; Visual Acuity | 2018 |
Genitourinary Tract Infection Due to Mycobacterium avium intracellulare Complex Infection in Pretransplant Setting With Recurrence Following Transplant: A Case Report.
Topics: Anti-Bacterial Agents; Ethambutol; Female; Fluoroquinolones; Humans; Immunocompromised Host; Kidney Transplantation; Latent Tuberculosis; Liver Transplantation; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence; Urinary Tract Infections | 2018 |
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Mexico; Middle Aged; Multivariate Analysis; Philippines; Pyrazinamide; Rifampin; Risk Factors; Vietnam; Washington; Young Adult | 2017 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |